Ramelteon and Citicoline for Delirium

Withdrawn before enrolling · Phase 4

Conditions studied: Delirium

In brief

Primary aim of this study is to assess the feasibility of conducting clinical research for delirium (confusion due to medical problems) at Clements University Hospital in Dallas, Texas. A secondary aim is to assess whether an FDA-approved sleeping aid called Ramelteon or an over-the-counter supplement called Citicoline are safe and beneficial in delirium.

Key facts

Study ID

NCT02840591

Run by

University of Texas Southwestern Medical Center

People needed

0

Starts

2016-07-01

Expected to finish

2017-11-01

Last updated by the study team

2017-11-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Admitted to inpatient units commonly known as 12-South or 12-North at Clements University Hospital
• Has capacity to give informed consent OR legally authorized representative is available at bedside
• Expected duration of hospitalization longer than 48 hours
• Fluent in English
• Can be screened by study physician within 24 hours of admission

You may not qualify if…

• History of angioedema or any other allergic reaction with previous ramelteon therapy
• Pregnant or currently breast-feeding
• Concurrent use of fluvoxamine
• Severe hepatic impairment
• Severe obstructive sleep apnea

Where it is running

• The University of Texas Southwestern Medical Center at Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.